Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001731122-23-001924
Filing Date
2023-10-23
Accepted
2023-10-20 21:47:23
Documents
6
Effectiveness Date
2023-10-23

Document Format Files

Seq Description Document Type Size
1 FORM S-8 e5115_s8.htm S-8 68951
2 EXHIBIT 5.1 e5115_ex5-1.htm EX-5.1 18097
3 EXHIBIT 23.1 e5115_ex23-1.htm EX-23.1 2656
4 EXHIBIT 99.1 e5115_ex99-1.htm EX-99.1 231249
5 EXHIBIT 107 e5115_ex107.htm EX-FILING FEES 15585
6 GRAPHIC image_001.jpg GRAPHIC 2040
  Complete submission text file 0001731122-23-001924.txt   340869
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO BIOSCIENCES INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-275132 | Film No.: 231338369
SIC: 2834 Pharmaceutical Preparations